An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases

Abstract
In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recogniz